Eric Low(@EricLow71) 's Twitter Profileg
Eric Low

@EricLow71

ID:1220978239

calendar_today26-02-2013 09:46:18

1,2K Tweets

921 Followers

1,0K Following

awechalekar(@awechalekar) 's Twitter Profile Photo

An exciting clinical research fellow in haematology post now open at UK National Amyloidosis Centre and UCLH amyloidosis/MGCS trials clinic - see - 2-3 yrs with opportunities to do a PhD at UCL. OutLandysh Society BSH - Haematology European Hematology Association ASH LinkedIn

account_circle
Hira Mian(@HiraSMian) 's Twitter Profile Photo

Everyone must come! Great science, great city, great food and you get to hang out with cool Canadian colleague hosts :) we look forward to welcoming everyone.

account_circle
Martin Kaiser(@MyMKaiser) 's Twitter Profile Photo

Many thanks, very kind. Deeply feel we should discuss the value of extended upfront risk molecular diagnostic tests more in , not only price. We might find that they will help allocate other rare resources like imaging or MRD tests throughout treatment phases better.

account_circle
Adele Fielding(@AdeleKFielding) 's Twitter Profile Photo

I am seeking a post doc (3 years) to work with me and my group Centre for Blood Research York Biomedical Research Institute University of York on the microenvironment in acute lymphoblastic leukaemia. Advert is live on U of York jobs ref 12484
Fabulous environment, great science.

account_circle
Jack Scannell(@JackScannell13) 's Twitter Profile Photo

$50 billion a year is spent on failed cancer drug development by the pharma industry. Our new paper is a case study on what goes wrong. Consilium Scientific John A Hickman
jamanetwork.com/journals/jaman…

account_circle
Duncan T Wilson(@DTWilson) 's Twitter Profile Photo

Join us tomorrow to hear Laura Flight on the interplay between health economics and adaptive designs, at the first Leeds CTRU seminar of the year.

account_circle
Martin Kaiser(@MyMKaiser) 's Twitter Profile Photo

Will be very interesting to see how this will work in practice - a fantastic, extremely scalable technology. And of course hoping patients may be included as well! BioNTech SE NCRI Partnership

ft.com/content/a0f741…

account_circle
Ben Derman(@bdermanmd) 's Twitter Profile Photo

OPTIMUM MUK9 Martin Kaiser: Extended 'kitchen sink' approach for ultra high risk . Amazing effort & it's paying off. 30-month PFS is 77%. MRD(-) rates sustained from post-ASCT to subsequent time points. Even OS signal very encouraging.

OPTIMUM MUK9 @MyMKaiser: Extended 'kitchen sink' approach for ultra high risk #mmsm. Amazing effort & it's paying off. 30-month PFS is 77%. MRD(-) rates sustained from post-ASCT to subsequent time points. Even OS signal very encouraging. #ASH22
account_circle
David Cairns(@kennycairns) 's Twitter Profile Photo

3/n MUKNine/OPTIMUM updated results show improving outcomes for UHiR MM patients and the benefits of specialist early- and late-phase trial teams working together to learn from data assets to shape novel designs Martin Kaiser Prof Sarah R Brown 💙 Myeloma UK ash.confex.com/ash/2022/webpr…

account_circle